Longboard Pharmaceuticals Stock Shares Outstanding
Longboard Pharmaceuticals fundamentals help investors to digest information that contributes to Longboard Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Longboard Stock. The fundamental analysis module provides a way to measure Longboard Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Longboard Pharmaceuticals stock.
Longboard |
Longboard Pharmaceuticals Company Shares Outstanding Analysis
Longboard Pharmaceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Longboard Pharmaceuticals Shares Outstanding | 34.44 M |
Most of Longboard Pharmaceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Longboard Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Longboard Pharmaceuticals has 34.44 M of shares currently outstending. This is 80.93% lower than that of the Biotechnology sector and 67.77% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 93.98% higher than that of the company.
Longboard Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Longboard Pharmaceuticals' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Longboard Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Longboard Pharmaceuticals by comparing valuation metrics of similar companies.Longboard Pharmaceuticals is currently under evaluation in shares outstanding category among its peers.
Longboard Fundamentals
Return On Equity | -0.47 | |||
Return On Asset | -0.31 | |||
Current Valuation | 2.06 B | |||
Shares Outstanding | 34.44 M | |||
Shares Owned By Insiders | 1.19 % | |||
Shares Owned By Institutions | 98.81 % | |||
Number Of Shares Shorted | 1.93 M | |||
Price To Book | 8.51 X | |||
EBITDA | (56.75 M) | |||
Net Income | (54.42 M) | |||
Cash And Equivalents | 87.42 M | |||
Cash Per Share | 5.09 X | |||
Total Debt | 475 K | |||
Debt To Equity | 0 % | |||
Current Ratio | 11.95 X | |||
Book Value Per Share | 7.05 X | |||
Cash Flow From Operations | (50.87 M) | |||
Short Ratio | 1.27 X | |||
Earnings Per Share | (2.25) X | |||
Target Price | 64.0 | |||
Number Of Employees | 50 | |||
Beta | 1.09 | |||
Market Capitalization | 2.34 B | |||
Total Asset | 50.7 M | |||
Retained Earnings | (140.56 M) | |||
Working Capital | 40.45 M | |||
Net Asset | 50.7 M |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Longboard Stock
If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Global Correlations Find global opportunities by holding instruments from different markets |